Variable | Valuea (NÂ =Â 85) |
---|---|
Age in years, mean ± standard deviation | 66.9 ± 15.9 |
Male gender | 33 (38.8) |
Comorbid conditions | |
 Malignancy | 41 (48.2) |
 Diabetes mellitus | 28 (32.9) |
 Corticosteroid/Immunosuppressive therapy | 22 (25.9) |
 Renal insufficiency | 11 (12.9) |
 Chronic pulmonary disease | 8 (9.4) |
Exposure to healthcare/invasive devices within 30Â days of current infection | |
 Hospital stay | |
  0–2 days | 50 (58.8) |
  3–5 days | 12 (14.1) |
  > 6 days | 23 (27.1) |
 Urinary catheter | |
  0–2 days | 69 (81.2) |
  3–5 days | 7 (8.2) |
  > 6 days | 9 (10.6) |
 Surgical procedure | 18 (21.2) |
Recent antibiotic use | |
 Within 24 h prior to enrollment | 15 (17.6) |
 For >48 h within 30 days prior to enrollment | 32 (37.6) |
Place of acquisition of infection | |
 Community-acquired | 37 (43.5) |
 Healthcare-associated | 29 (34.2) |
 Hospital-acquired | 19 (22.3) |
Site of infection | |
 Urinary tract | 74 (87.1) |
 Skin and soft tissue | 6 (7.1) |
 Bloodstream | 4 (4.7) |
 Respiratory tract | 1 (1.2) |